The utility of packed-column supercritical, subcritical, and enhanced fluid
ity liquid chromatographies (pcSFC) for high-throughput applications has in
creased during the past few years. In contrast to traditional reversed-phas
e liquid chromatography, the addition of a volatile component to the mobile
phase, such as CO2, produces a lower mobile-phase viscosity. This allows t
he use of higher flow rates which can translate into faster analysis times.
In addition, the resulting mobile phase is considerably more volatile than
the aqueous-based mobile phases that are typically used with LC-MS, allowi
ng the entire effluent to be directed into the MS interface. High-throughpu
t bioanalytical quantitation using pcSFC-MS/MS for pharmacokinetics applica
tions is demonstrated in this report using dextromethorphan as a model comp
ound. Plasma samples were prepared by automated liquid/liquid extraction in
the 96-well format prior to pcSFC-MS/MS analysis. Three days of validation
data are provided along with study sample data from a patient dosed with c
ommercially available Vicks 44, Using pcSFC and MS/MS, dextromethorphan was
quantified in 96-well plates at a rate of similar to 10 min/plate with ave
rage intraday accuracy of 9% or better. Daily relative standard deviations
(RSDs) were less than 10% for the 2.21 and 14.8 ng/mL quality control (QC)
samples, while the RSDs were less than 15% at the 0.554 ng/mL QC level.